227 related articles for article (PubMed ID: 32840016)
1. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.
Tserga E; Moreno-Paublete R; Sarlus H; Björn E; Guimaraes E; Göritz C; Cederroth CR; Canlon B
FASEB J; 2020 Oct; 34(10):13978-13992. PubMed ID: 32840016
[TBL] [Abstract][Full Text] [Related]
2. Auditory synaptopathy in mice lacking the glutamate transporter GLAST and its impact on brain activity.
Tserga E; Damberg P; Canlon B; Cederroth CR
Prog Brain Res; 2021; 262():245-261. PubMed ID: 33931183
[TBL] [Abstract][Full Text] [Related]
3. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cochlear toxicity in response to chronic 3,3'-iminodipropionitrile in mice reveals early and reversible functional loss that precedes overt histopathology.
Greguske EA; Llorens J; Pyott SJ
Arch Toxicol; 2021 Mar; 95(3):1003-1021. PubMed ID: 33495873
[TBL] [Abstract][Full Text] [Related]
5. Chronotolerance for cisplatin ototoxicity in the rat.
Bielefeld EC; Markle A; DeBacker JR; Harrison RT
Hear Res; 2018 Dec; 370():16-21. PubMed ID: 30253329
[TBL] [Abstract][Full Text] [Related]
6. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
8. Functional roles of high-affinity glutamate transporters in cochlear afferent synaptic transmission in the mouse.
Chen Z; Kujawa SG; Sewell WF
J Neurophysiol; 2010 May; 103(5):2581-6. PubMed ID: 20220082
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
Li Y; Ding D; Jiang H; Fu Y; Salvi R
Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of adenosine receptors in the cochlea by cisplatin.
Ford MS; Nie Z; Whitworth C; Rybak LP; Ramkumar V
Hear Res; 1997 Sep; 111(1-2):143-52. PubMed ID: 9307320
[TBL] [Abstract][Full Text] [Related]
13. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
14. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
[TBL] [Abstract][Full Text] [Related]
15. Experimental topical ototoxicity investigations: can we underestimate unilateral ototoxicity because of cross-hearing?
Ikiz AO
Otolaryngol Head Neck Surg; 2000 May; 122(5):779-80. PubMed ID: 10793371
[No Abstract] [Full Text] [Related]
16. Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.
Maruyama A; Kawashima Y; Fukunaga Y; Makabe A; Nishio A; Tsutsumi T
Hear Res; 2024 Jun; 447():109013. PubMed ID: 38718672
[TBL] [Abstract][Full Text] [Related]
17. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study.
Tanyeli TT; Karadaş H; Akyıldız İ; Gökdoğan O; Sönmez Ç; Çavuş ME; Kaptan Z; Uzunkulaoğlu H; Arslan N; Zeybek ND
J Int Adv Otol; 2019 Aug; 15(2):237-246. PubMed ID: 31347504
[TBL] [Abstract][Full Text] [Related]
18. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Church MW; Kaltenbach JA; Blakley BW; Burgio DL
Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
[TBL] [Abstract][Full Text] [Related]
19. Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity.
Chen Y; Bielefeld EC; Mellott JG; Wang W; Mafi AM; Yamoah EN; Bao J
J Assoc Res Otolaryngol; 2021 Apr; 22(2):107-126. PubMed ID: 33415542
[TBL] [Abstract][Full Text] [Related]
20. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
